Lineage Cell Therapeutics Inc (NYSE American:LCTX)
| 1.65 Delayed Data As of 4:00pm ET |  -0.04 / -2.37%Today’s Change | 1.10 Today|||52-Week Range 2.81 | -32.65% Year-to-Date |
Latest LCTX News | Press Releases
No recent news for Lineage Cell Therapeutics Inc.
Today’s Trading
| Previous close | 1.69 |
| Today’s open | 1.69 |
| Day’s range | 1.64 - 1.75 |
| Volume | 637,720 |
| Average volume (3 months) | 903,958 |
| Market cap | $268.2M |
Data as of 4:00pm ET, 07/06/2022
Growth & Valuation
| Earnings growth (last year) | -90.04% |
| Earnings growth (this year) | +41.21% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +404.01% |
| P/E ratio | NM |
| Price/Sales | 103.45 |
| Price/Book | 2.90 |
Competitors
Data as of 3:59pm ET, 07/06/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $3.9M |
| Annual profit (last year) | -$43.0M |
| Net profit margin | -1,104.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Carlsbad, California |
Forecasts
